Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
Abstract Aims To explore the correlation between cardiac‐related comorbidities, cardiac biomarkers, acute myocardial injury, and severity level, outcomes in COVID‐19 patients. Method Pubmed, Web of Science, Embase, CNKI, VIP, Wanfang, Cochrane Library databases, medRxiv, and Sinomed were reviewed sy...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/244103e101cf48e2aee51b9c0d937652 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:244103e101cf48e2aee51b9c0d937652 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:244103e101cf48e2aee51b9c0d9376522021-11-12T19:57:13ZCardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis2050-452710.1002/iid3.471https://doaj.org/article/244103e101cf48e2aee51b9c0d9376522021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.471https://doaj.org/toc/2050-4527Abstract Aims To explore the correlation between cardiac‐related comorbidities, cardiac biomarkers, acute myocardial injury, and severity level, outcomes in COVID‐19 patients. Method Pubmed, Web of Science, Embase, CNKI, VIP, Wanfang, Cochrane Library databases, medRxiv, and Sinomed were reviewed systemically. Various types of clinical research reporting cardiac‐related comorbidities, cardiac biomarkers including lactate dehydrogenase (LDH), troponin I (TnI), high sensitivity troponin I (hs‐TnI), creatine kinase (CK), creatine kinase–MB (CK‐MB), myoglobin (Myo), N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) and acute cardiac injury grouped by severity of COVID‐19 were included. Outcome measures were events and total sample size for comorbidities, acute cardiac injury, and laboratory parameters of these biomarkers. The study was performed with Stata version 15.1. Results Seventy studies, with a total of 15,354 cases were identified. The results showed that COVID‐19's severity was related to cardiovascular disease. Similar odds ratios (ORs) were achieved in hypertension except for severe versus critical group (OR = 1.406; 95% CI, 0.942–2.097; p = .095). The relative risk (RR) of acute cardiac injury is 7.01 (95% CI, 5.64–8.71) in non‐survivor cases. When compared with the different severity of cardiac biomarkers, the pool OR of CK, CK‐MB, TnI, Myo and LDH were 2.683 (95% CI, 0.83–8.671; p = .106; I2 = 0%), 2.263 (95% CI, 0.939–5.457; p = .069), 1.242 (95% CI, 0.628–2.457; p = .534), 1.756 (95% CI, 0.608–5.071; p = .298; I2 = 42.3%), 1.387 (95% CI, 0.707–2.721; p = .341; I2 = 0%) in the critical versus severe group, whose trends were not similar to other groups. The standard mean differences (SMD) of CK and TnI in the critical versus severe group were 0.09 (95% CI, −0.33 to 0.50; p = .685; I2 = 65.2%), 0.478 (95% CI, −0.183 to 1.138; p = .156; I2 = 76.7%), which means no difference was observed in the serum level of these indicators. Conclusion Most of the findings clearly indicate that hypertension, cardiovascular disease, acute cardiac injury, and related laboratory indicators are associated with the severity of COVID‐19. What is now needed are cross‐national prospectively designed observational or clinical trials that will help improve the certainty of the available evidence and treatment decisions for patients.Zhengchuan ZhuMiaoran WangWei LinQiaoyan CaiLing ZhangDaxin ChenFei LiuXiaoman XiongJianfeng ChuJun PengKeji ChenWileyarticleacute myocardial injurycardiac biomarkerscomorbiditiesCOVID‐19meta‐analysisSARS‐CoV‐2Immunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1071-1100 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
acute myocardial injury cardiac biomarkers comorbidities COVID‐19 meta‐analysis SARS‐CoV‐2 Immunologic diseases. Allergy RC581-607 |
| spellingShingle |
acute myocardial injury cardiac biomarkers comorbidities COVID‐19 meta‐analysis SARS‐CoV‐2 Immunologic diseases. Allergy RC581-607 Zhengchuan Zhu Miaoran Wang Wei Lin Qiaoyan Cai Ling Zhang Daxin Chen Fei Liu Xiaoman Xiong Jianfeng Chu Jun Peng Keji Chen Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis |
| description |
Abstract Aims To explore the correlation between cardiac‐related comorbidities, cardiac biomarkers, acute myocardial injury, and severity level, outcomes in COVID‐19 patients. Method Pubmed, Web of Science, Embase, CNKI, VIP, Wanfang, Cochrane Library databases, medRxiv, and Sinomed were reviewed systemically. Various types of clinical research reporting cardiac‐related comorbidities, cardiac biomarkers including lactate dehydrogenase (LDH), troponin I (TnI), high sensitivity troponin I (hs‐TnI), creatine kinase (CK), creatine kinase–MB (CK‐MB), myoglobin (Myo), N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) and acute cardiac injury grouped by severity of COVID‐19 were included. Outcome measures were events and total sample size for comorbidities, acute cardiac injury, and laboratory parameters of these biomarkers. The study was performed with Stata version 15.1. Results Seventy studies, with a total of 15,354 cases were identified. The results showed that COVID‐19's severity was related to cardiovascular disease. Similar odds ratios (ORs) were achieved in hypertension except for severe versus critical group (OR = 1.406; 95% CI, 0.942–2.097; p = .095). The relative risk (RR) of acute cardiac injury is 7.01 (95% CI, 5.64–8.71) in non‐survivor cases. When compared with the different severity of cardiac biomarkers, the pool OR of CK, CK‐MB, TnI, Myo and LDH were 2.683 (95% CI, 0.83–8.671; p = .106; I2 = 0%), 2.263 (95% CI, 0.939–5.457; p = .069), 1.242 (95% CI, 0.628–2.457; p = .534), 1.756 (95% CI, 0.608–5.071; p = .298; I2 = 42.3%), 1.387 (95% CI, 0.707–2.721; p = .341; I2 = 0%) in the critical versus severe group, whose trends were not similar to other groups. The standard mean differences (SMD) of CK and TnI in the critical versus severe group were 0.09 (95% CI, −0.33 to 0.50; p = .685; I2 = 65.2%), 0.478 (95% CI, −0.183 to 1.138; p = .156; I2 = 76.7%), which means no difference was observed in the serum level of these indicators. Conclusion Most of the findings clearly indicate that hypertension, cardiovascular disease, acute cardiac injury, and related laboratory indicators are associated with the severity of COVID‐19. What is now needed are cross‐national prospectively designed observational or clinical trials that will help improve the certainty of the available evidence and treatment decisions for patients. |
| format |
article |
| author |
Zhengchuan Zhu Miaoran Wang Wei Lin Qiaoyan Cai Ling Zhang Daxin Chen Fei Liu Xiaoman Xiong Jianfeng Chu Jun Peng Keji Chen |
| author_facet |
Zhengchuan Zhu Miaoran Wang Wei Lin Qiaoyan Cai Ling Zhang Daxin Chen Fei Liu Xiaoman Xiong Jianfeng Chu Jun Peng Keji Chen |
| author_sort |
Zhengchuan Zhu |
| title |
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis |
| title_short |
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis |
| title_full |
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis |
| title_fullStr |
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis |
| title_full_unstemmed |
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis |
| title_sort |
cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (covid‐19): a systematic review and meta‐analysis |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/244103e101cf48e2aee51b9c0d937652 |
| work_keys_str_mv |
AT zhengchuanzhu cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT miaoranwang cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT weilin cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT qiaoyancai cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT lingzhang cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT daxinchen cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT feiliu cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT xiaomanxiong cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT jianfengchu cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT junpeng cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis AT kejichen cardiacbiomarkerscardiacinjuryandcomorbiditiesassociatedwithsevereillnessandmortalityincoronavirusdisease2019covid19asystematicreviewandmetaanalysis |
| _version_ |
1718430303189467136 |